专题:Diet, Metabolism, and Disease

This cluster of papers explores the impact of fructose consumption on metabolic health, including its association with metabolic syndrome, insulin resistance, obesity, cardiovascular disease, hypertension, lipid dysregulation, and hepatic steatosis. The research delves into the effects of dietary fructose on glucose metabolism and its potential role in the development of various metabolic disorders.
最新文献
Prevalence of subclinical hypothyroidism and longitudinal thyroid-stimulating hormone changes in youth with metabolic dysfunction–associated steatotic liver disease: An observational study

article Full Text OpenAlex

Mechanistic Links between Central Obesity and Cardiorenal Metabolic Diseases

article Full Text OpenAlex

A new mechanism of thyroid hormone receptor β agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles

article Full Text OpenAlex

Assessment of the appropriate cutoff points for anthropometric indices and their relationship with cardio-metabolic indices to predict the risk of metabolic associated fatty liver disease

article Full Text OpenAlex

Designable immobilization of D-allulose 3-epimerase on bimetallic organic frameworks based on metal ion compatibility for enhanced D-allulose production

article Full Text OpenAlex

The Associations between Healthy Eating Patterns and Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Case–Control Study

article Full Text OpenAlex

Effect of intermittent fasting 16:8 and 14:10 compared with control‐group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial

article Full Text OpenAlex

Severe obesity is associated with worse outcomes than lean metabolic dysfunction–associated steatotic liver disease

article Full Text OpenAlex

Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study

article Full Text OpenAlex

Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease

editorial Full Text OpenAlex

近5年高被引文献
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal

preprint Full Text OpenAlex 23691 FWCI1509.60534046

Non-alcoholic fatty liver disease

review Full Text OpenAlex 2416 FWCI345.54240432

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

article Full Text OpenAlex 2323 FWCI820.14536295

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

review Full Text OpenAlex 2282 FWCI810.96594864

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

review Full Text OpenAlex 2166 FWCI766.12804029

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

article Full Text OpenAlex 1762 FWCI621.37573775

Mechanisms and disease consequences of nonalcoholic fatty liver disease

review Full Text OpenAlex 1619 FWCI228.12145764

Obesity: Epidemiology, Pathophysiology, and Therapeutics

review Full Text OpenAlex 1078 FWCI121.88853651

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

article Full Text OpenAlex 985 FWCI907.72980867

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

article Full Text OpenAlex 928 FWCI126.38152768